70.000 DRUG DISPENSING

70.995             Generic Drug Labeling: All generic medications should have an identifying number or symbol.  (Council 12/13/84; Reaffirmed HOD 2013; Reaffirmed HOD 2023; Reaffirmed HOD 2024)

70.994             Qualitative Labeling of All Drugs: MSSNY strongly supports efforts to promote qualitative drug labeling of all drugs, requiring the active and inactive ingredients of all drugs (over-the-counter as well as prescription) to be listed on the label or package insert for the drug.  (Council 12/13/84; Reaffirmed HOD 2013; Reaffirmed HOD 2023; Reaffirmed HOD 2024)

70.993             “Look-Alike” Drugs:  MSSNY encourages federal legislation prohibiting the manufacture, sale, distribution or gift of substances which look like controlled substances (“Look-alikes”). MSSNY supports stricter legislation controlling the advertising and sale of “Look-Alike” medications.  (Council 12/13/84; Reaffirmed HOD 2013; Reaffirmed HOD 2023)

70.992             Marijuana:  SUNSET HOD 2013

70.991             Physician’s Right to Dispense Drugs and Devices:  MSSNY supports the position taken by the AMA House of Delegates in June, 1986 to support the physician’s right to dispense drugs and devices when it is in the best interest of the patient and consistent with the AMA’s Ethical Guidelines.  (Council 4/23/87; Reaffirmed HOD 2013; Reaffirmed HOD

70.990             Political Pressure and Release of New Medications:  SUNSET HOD 2013

70.989             FDA ‘A’ Generic Drug Prescribing:  SUNSET HOD 2013

70.988             Opposition to Legalization of Drugs for Non-Medically Indicated Uses: SUNSET HOD 2024

70.987             Generic Drug Prescription:   SUNSET HOD 2014

70.986             New Medications – Testing:  SUNSET HOD 2014